Intellia Therapeutics, Inc.

NTLA

—

Advanced chart & tools →

Intellia Therapeutics, Inc.NTLA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.81

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$67.67M

Net income

$-412.69M

Net margin

-609.9%

Gross margin

—

Dividends & financials

Intellia Therapeutics, Inc. (NTLA) reported revenue of $67.67M and net income of $-412.69M, or $-3.81 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.